BLOG

Novel therapy safe, effective in acute, severe alcoholic hepatitis

In this exclusive video from The Liver Meeting 2019, Tarek Hassanein, MD, FAASLD, professor of medicine at UC San Diego Health and medical director of Southern California GI and Liver Centers, discusses results of a phase 2a study, which demonstrated that DUR-928 was well-tolerated and effective in patients with acute alcoholic hepatitis.

Back to the Blog .st0{stroke:#000;stroke-width:3}.st0,.st1{fill:none}